TrialBone marrow transplantation2014

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.

S K Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.